Powder: -20°C for 3 years | In solvent: -80°C for 1 year
HLI373 is an efficacious Hdm2 inhibitor. Hdm2 is an ubiquitin ligase (E3). HLI373 is effective in inducing apoptosis of several tumor cells that are sensitive to DNA-damaging agents [1]. HLI 373 also shows prominent antimalarial activity [2].
Pack Size | Availability | Price/USD | Quantity |
---|---|---|---|
25 mg | 6-8 weeks | $ 1,627.00 | |
50 mg | 6-8 weeks | $ 2,438.00 |
Description | HLI373 is an efficacious Hdm2 inhibitor. Hdm2 is an ubiquitin ligase (E3). HLI373 is effective in inducing apoptosis of several tumor cells that are sensitive to DNA-damaging agents [1]. HLI 373 also shows prominent antimalarial activity [2]. |
In vitro | HLI373, at concentrations ranging from 3-15 μM over 15 hours, preferentially induces cell death in tumor cells harboring wild type p53, according to study [1]. At higher doses (10-50 μM), it dose-dependently stabilizes Hdm2, while a lower concentration of 3 μM activates p53 transcription. This compound effectively blocks the auto-ubiquitylation of Hdm2 and, when cells are co-transfected with p53 and Hdm2, HLI373 can prevent the degradation of p53, especially at 5-10 μM after 8 hours of treatment. Moreover, it increases both p53 and Hdm2 protein levels in cells. Notably, HLI373 demonstrates potent activity against both chloroquine-sensitive and resistant strains of P. falciparum, displaying IC50 values below 6 μM and inducing early growth inhibition. Functioning as an MDM2 inhibitor by targeting its C-terminus, HLI373 disrupts the ubiquitin E3 ligase activity of MDM2, which is key to the ubiquitylation of p53, highlighting its potential in cancer therapy. In cell viability assays, it was shown to cause increased cell death in wild type p53 mouse embryo fibroblasts (MEFs) in a dose-dependent manner, whereas p53-deficient MEFs exhibited resistance. Western blot analyses revealed that the compound prevents p53 degradation in U2OS cells when co-transfected with p53 and Hdm2 encoding plasmids. |
Molecular Weight | 341.41 |
Formula | C18H23N5O2 |
CAS No. | 502137-98-6 |
Powder: -20°C for 3 years | In solvent: -80°C for 1 year
You can also refer to dose conversion for different animals. More
bottom
Please see Inhibitor Handling Instructions for more frequently ask questions. Topics include: how to prepare stock solutions, how to store products, and cautions on cell-based assays & animal experiments, etc.
HLI 373 502137-98-6 HLI-373 HLI373 inhibitor inhibit